Home Tools
Log in
Cart

NVP-TAE 226

Catalog No. T1918   CAS 761437-28-9
Synonyms: TAE226

NVP-TAE 226 (TAE226) is an effective FAK inhibitor (IC50: 5.5 nM) and most effective to Pyk2(IC50: 3.5 nM); 10- to 100-fold less effective against IGF-1R, InsR, c-Met, and ALK.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
NVP-TAE 226 Chemical Structure
NVP-TAE 226, CAS 761437-28-9
Pack Size Availability Price/USD Quantity
1 mg In stock $ 41.00
2 mg In stock $ 57.00
5 mg In stock $ 103.00
10 mg In stock $ 166.00
25 mg In stock $ 277.00
50 mg In stock $ 397.00
100 mg In stock $ 597.00
1 mL * 10 mM (in DMSO) In stock $ 103.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 99.17%
Purity: 98.07%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description NVP-TAE 226 (TAE226) is an effective FAK inhibitor (IC50: 5.5 nM) and most effective to Pyk2(IC50: 3.5 nM); 10- to 100-fold less effective against IGF-1R, InsR, c-Met, and ALK.
Targets&IC50 FAK:5.5 nM, PYK2:3.5 nM
In vitro In in vivo models, NVP-TAE226 (100 mg/kg, p.o.) significantly hindered the growth of human pancreatic tumor MIA PaCa-2 without affecting body weight. Moreover, NVP-TAE226 demonstrated a dose-dependent inhibition of growth and lung metastasis in 4T1 murine mammary tumors, correlated with the suppression of FAK autophosphorylation on Y397 and Akt phosphorylation on serine 473. At a dosage of 75 mg/kg, NVP-TAE226 significantly increased the survival rate of mice bearing intracranial glioma xenografts. Additionally, in a human colorectal cancer SCID mouse model, NVP-TAE226 (100 mg/kg, p.o.) markedly reduced microvessel density.
In vivo NVP-TAE226 (0.1-10 μM) inhibits microtubule formation in HMEC1 cells and suppresses serum starvation-induced autophosphorylation of FAK(Tyr397) in U87 cells at concentrations below 1 μM. It also inhibits IGF-I-induced phosphorylation of IGF-1R and its downstream target gene activities, including MAPK and Akt in U87 and U251 cells at concentrations under 1 μM. Moreover, NVP-TAE226 at 1 μM inhibits tumor cell invasion by more than 50% in vitro assays on an artificial basement membrane for glioblastoma cell lines. It induces G(2)-M phase arrest in glioblastoma cell lines, including those with wild-type p53, while those bearing mutant p53 undertake apoptosis, evidenced by the activation of caspase-3/7, poly(ADP-ribose) polymerase cleavage, and annexin V apoptosis assays. In the neuroblastoma cell line SK-N-AS, NVP-TAE226 at 5 μM inhibits FAK phosphorylation and at concentrations below 10 μM decreases cell viability, induces cell cycle arrest, and increases apoptosis. In U87 and U251 cells, it impedes tumor cell growth and weakens the G(2)-M cell cycle process related to reduced expression of cyclin B1 and phosphorylated cdc2(Tyr15) proteins at concentrations below 10 μM.
Kinase Assay Kinase assay: Kinase activities are assayed in Buffer A or C at 30°C, at a final ATP concentration of 15 μM. Blank values are subtracted and activities calculated as pmoles of phosphate incorporated during a 10 min incubation. Controls are performed with appropriate dilutions of dimethylsulfoxide. In a few cases phosphorylation of the substrate is assessed by autoradiography after SDS-PAGE. GSK-3α/β is purified from porcine brain by affinity chromatography on immobilized axin. It is assayed, following a 1/100 dilution in 1 mg BSA/ml 10 mM DTT, with 5 μl 40 μM GS-1 peptide, a specific GSK-3 substrate, (YRRAAVPPSPSLSRHSSPHQSpEDEEE), in buffer A, in the presence of 15 μM [γ-32P] ATP (3,000 Ci/mmol; 1 mCi/ml) in a final volume of 30 μl. After 30 min incubation at 30°C, 25 μl aliquots of supernatant are spotted onto 2.5 × 3 cm pieces of Whatman P81 phosphocellulose paper, and 20 seconds later, the filters are washed five times (for at least 5 min each time) in a solution of 10 ml phosphoric acid/liter of water. The wet filters are counted in the presence of 1 ml ACS scintillation fluid.
Cell Research Cell cultures are harvested with 0.05% trypsin and seeded in triplicate at 2 × 104 in 24-well culture plates for 24 h before drug treatment. Culture medium is used for mock treatment. Cells are harvested at the indicated day after treatment, and viable cells are counted using the Vi-cell viability analyze(Only for Reference)
Synonyms TAE226
Molecular Weight 468.94
Formula C23H25ClN6O3
CAS No. 761437-28-9

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 87 mg/mL (185.5 mM)

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

H2O: < 1 mg/mL (insoluble or slightly soluble)

TargetMolReferences and Literature

1. Liu TJ, et al. Mol Cancer Ther, 2007, 6(4), 1357-1367. 2. Beierle EA, et al. Cancer Invest, 2008, 26(2), 145-151. 3. Schultze A, et al. Invest New Drugs, 2010, 28(6), 825-833. 4. Su Y, Li R, Ning X, et al. Discovery of 2, 4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities[J]. European Journal of Medicinal Chemistry. 2019 May 18;177:32-46.

TargetMolCitations

1. Sang M, Luo R, Bai Y, et al. BHQ-Cyanine-Based “Off–On” Long-Circulating Assembly as a Ferroptosis Amplifier for Cancer Treatment: A Lipid-Peroxidation Burst Device. ACS Applied Materials & Interfaces. 2019, 11(46): 42873-42884 2. Zheng Q, Zou Y, Teng P, et al. Mechanosensitive Channel PIEZO1 Senses Shear Force to Induce KLF2/4 Expression via CaMKII/MEKK3/ERK5 Axis in Endothelial Cells. Cells. 2022, 11(14): 2191 3. Su Y, Li R, Ning X, et al. Discovery of 2, 4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities. European Journal of Medicinal Chemistry. 2019 May 18;177:32-46 4. Li R, Gong L, Sun J, et al.Discovery of 2, 4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors.Bioorganic Chemistry.2024: 107134.

Related compound libraries

This product is contained In the following compound libraries:
Anti-Cancer Active Compound Library Tyrosine Kinase Inhibitor Library Kinase Inhibitor Library Inhibitor Library Bioactive Compounds Library Max Angiogenesis related Compound Library Bioactive Compound Library Anti-Pancreatic Cancer Compound Library Cytokine Inhibitor Library Anti-Lung Cancer Compound Library

Related Products

Related compounds with same targets
Decursin Glaucocalyxin A SCFSkp2-IN-2 Asperosaponin VI PI3Kδ-IN-16 SCH79797 dihydrochloride Verbascoside Volasertib

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

NVP-TAE 226 761437-28-9 Angiogenesis Apoptosis Cytoskeletal Signaling Tyrosine Kinase/Adaptors FAK c-Met/HGFR PYK2 IGF-1R inhibit TAE 226 TAE-226 Focal adhesion kinase Insulin Receptor TAE226 NVP-TAE-226 Inhibitor NVP-TAE226 PTK2 protein tyrosine kinase 2 Pyk2 NVPTAE 226 Proline-rich tyrosine kinase 2 NVP TAE 226 PTK2 inhibitor

 

TargetMol